- Brooker A F, Bowerman J W, Robinson R A, Riley L H, Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg (Am) 1973; 55: 1629–32
- Burd T A, Lowry K J, Anglen J O. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures. J Bone Joint Surg (Am) 2001; 83: 1783–8
- Chan C C, Boyce S, Brideau C, et al. Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone)]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther 1999; 290: 551–60
- Gunal I, Hazer B, Seber S, et al. Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients. Acta Orthop Scand 2001; 72: 467–9
- Hawkey C, Kahan A, Steinbruck K, et al. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA study group. Meloxicam large-scale international study: safety assessment. Br J Rheumatol 1998; 37: 937–45
- Kjaersgaard-Andersen P, Nafei A, Teichert, et al. Indomethacin for prevention of heterotopic ossification. A randomised controlled study in 41 hip arthroplasties. Acta Orthop Scand 1993; 64: 639–42
- Knelles D, Barthel T, Karrer A, et al. Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Joint Surg (Br) 1997; 79: 596–602
- Kolbl O., Knelles D, Barthel T, et al. Randomised trial comparing early postoperative irradiation vs. the use of non-steroidal anti-inflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement. Int J Radiat Oncol Biol Phys 1997; 39: 961–6
- Neal B C, Rodgers A, Clark T, et al. A systematic survey of 13 randomised trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 2000; 71: 122–8
- Nilsson O S. Non-steroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty. Semin Arthroplasty 1992; 3: 172–7
- Nilsson O S. Heterotopic ossification. Acta Orthop Scand 1998; 69: 103–6
- Pairet M, van Ryn J, Schierok H, et al. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′-isomer. Inflamm Res 1998; 47: 270–6
- Sell S, Willms R, Jany R, et al. The suppression of heterotopic ossifications: radiation versus NSAID therapy - a prospective study. J Arthroplasty 1998; 13: 854–9
- Sodemann B, Persson P E, Nilsson O S. Prevention of heterotopic ossification by non-steroid anti-inflammatory drugs after total hip arthroplasty. Clin Orthop 1988; 237: 158–63
- Thomas B J, Amstutz H, Prevention C. Heterotopic bone formation: clinical experience with diphosphonates. Hip 1987; 59–69
- Tozun R, Pinar H, Yesiller E, Hamzaoglu A. Indomethacin for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 1992; 7: 57–61
- Wurnig C, Eyb R, Auersperg V. Indomethacin for prevention of ectopic ossification in cementless hip arthroplasties. A prospective 1-year study of 100 cases. Acta Orthop Scand 1992; 63: 628–30
Acta Orthopaedica Scandinavica
Volume 73, 2002 - Issue 6